End-of-Life Decisions: A Cross-National Study of Treatment Preference Discussions and Surrogate Decision-Maker Appointments

• Natalie Evans ,

  * E-mail: n.evans@vumc.nl

  Affiliation Department of Public and Occupational Health, EMGO+ Institute, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• H. Roeline Pasman,

  Affiliation Department of Public and Occupational Health, EMGO+ Institute, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• Tomás Vega Alonso,

  Affiliation Public Health Directorate, Ministry of Health (Dirección General de Salud Pública, Consejería de Sanidad), Valladolid, Castille and León, Spain

  ⨯
• Lieve Van den Block,

  Affiliation End-of-Life Care Research Group, Vrije Universiteit Brussel, Brussels, Belgium

  ⨯
• Guido Miccinesi,

  Affiliation Clinical and Descriptive Epidemiology Unit, Cancer Prevention and Research Institute, (ISPO – L’Istituto per lo Studio e la Prevenzione Oncologica), Florence, Italy

  ⨯
• Viviane Van Casteren,

  Affiliation Scientific Institute of Public Health (WIV-ISP - Wetenschappelijk Instituut Volksgezondheid, Institut Scientifique de Santé Publique), Brussels, Belgium

  ⨯
• Gé Donker,

  Affiliation Netherlands Institute of Health Services Research (NIVEL - Nederlands instituut voor onderzoek van de gezondheidszorg), Utrecht, The Netherlands

  ⨯
• Stefano Bertolissi,

  Affiliation Italian Society of General Practice (SIMG – Società Italiana di Medicina Generale), Florence, Italy

  ⨯
• Oscar Zurriaga,

  Affiliations Public Health and Research General Directorate, Valencian Regional Health Administration, Valencia, Spain, Higher Public Health Research Centre (CSISP - Centro Superior de Investigacion en Salud Pública), Valencia, Spain, Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP - El Consorcio de Investigación Biomédica de Epidemiología y Salud Pública), Madrid, Spain

  ⨯
• Luc Deliens,

  Affiliations Department of Public and Occupational Health, EMGO+ Institute, VU University Medical Center, Amsterdam, The Netherlands, End-of-Life Care Research Group, Vrije Universiteit Brussel, Brussels, Belgium

  ⨯
• Bregje Onwuteaka-Philipsen,

  Affiliation Department of Public and Occupational Health, EMGO+ Institute, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• on behalf of EUROIMPACT

  ¶Membership of EUROIMPACT is provided in the Acknowledgments.

  ⨯